Abbott completes acquisition of Cardiovascular Systems, Inc.

Abbott has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system for treating peripheral and coronary artery disease. CSI became a wholly owned subsidiary of Abbott.

“The acquisition of CSI is a component of an overall investment in our vascular portfolio that enhances our ability to care for patients with peripheral and coronary artery disease.”prnewswire.com

• 1 source
• prnewswire.comAbbott Completes Acquisition of Cardiovascular Systems, Inc.AbbottApr 27, 2023

Summarized from public sources; check the original articles before acting on it.